Clinical Pharmacology Considerations for Peptide Drug Products; Draft Guidance for Industry; Availability
🏛 Food and Drug Administration (FDA)FDA-2023-D-3391
Documents
1
Total comments
2
2 awaiting analysis
Comment status
Open
Last activity
Feb 9, 2024
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
OtherDec 11, 2023
Clinical Pharmacology Considerations for Peptide Drug Products
Guidance for Industry - DRAFT GUIDANCEClosed on Dec 12, 2023💬 2 comments · 2 awaiting analysis